The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials
Abstract
Background Diabetes mellitus is a frequent comorbid condition in patients with chronic heart failure (CHF) and confers a worse prognosis. Furthermore, although patients with CHF derive considerable benefit from beta-blockers, these agents are thought by many physicians to be contraindicated in patients with diabetes mellitus. Most published studies on beta-blockers in CHF have been unable to reach definitive conclusions about the mortality benefits of these agents in patients with diabetes mellitus. We therefore performed a meta-analysis of beta-blocker trials that reported mortality outcomes in patients with diabetes mellitus who had CHF to pool all available trial evidence on the benefits (or otherwise) of these agents in this setting.Methods All-cause mortality data on patients with diabetes mellitus were obtained from all completed beta-blocker CHF randomized placebo-controlled trials involving >100 patients exposed to beta-blockers, in which outcomes in patients with diabetes mellitus were described. When events were not directly reported, risk ratios (RRs) were derived from analysis of figures and other manuscript data. Results were pooled with the Mantel-Haenszel method.Results A total of 24.6% of patients were reported to have diabetes mellitus in the 6 studies analyzed (Australia and New Zealand [ANZ]-Carvedilol, Beta-blocker Evaluation of Survival Trial [BEST], Carvedilol US Trials, Cardiac Insufficiency Bisoprolol Study [CIBIS-II], Carvedilol Prospective Randomized Cumulative Survival Trial [COPERNICUS], and Metoprolol Controlled-release Randomized Intervention Trial in Heart Failure [MERIT-HF]). Patients with diabetes mellitus had increased mortality rates overall compared with subjects without diabetes mellitus (RR, 1.25; 95% CI, 1.15-1.36; P <.001). Compared with placebo, beta-blocker therapy for CHF was beneficial in patients with diabetes mellitus (RR, 0.84; 95% CI, 0.73-0.96; P =.011) and in subjects without diabetes mellitus (RR, 0.72; 95% CI, 0.65-0.79; P <.001). The absolute risk reduction in mortality with beta-blocker therapy was greater in patients with heart failure but without diabetes mellitus than in patients with diabetes mellitus (P =.023).Conclusions Patients with diabetes mellitus and CHF appear to derive prognostic benefit from beta-blocker therapy, although the magnitude of that benefit is somewhat less than that observed in subjects without diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a meta-analysis of six trials, beta-blocker therapy reduced all-cause mortality in patients with T2DM (HR 0.84) similarly to those without T2DM (HR 0.72).156”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [156]
Citations
Cites
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Lechat, P. P., Brunhuber, K., Hofmann, R., Kuhn, P., Nesser, H., Slany, J., Weihs, W., Wiedermann, C. J., Wimmer, H., van Mieghem, W., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,922
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,651
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,386
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, Å. C., Swedberg, K. B., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,223
Research works printed but not linked: 2
- Mohacsi, 2001, Should physicians avoid the use of beta-blockers in patients with heart failure who have diabetes? Results of the COPERNICUS study, Circulation, 104, II-754
- Chavey, 2001, Guideline for the management of heart failure caused by systolic dysfunction, Am Fam Physician, 64, 1045
Cited by
Sorted by citations
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,994
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary
Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,644
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Wang, C. C. L., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,222
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ōno, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 720
Heart Failure in Type 2 Diabetes Mellitus
Kenny, H., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 682
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000691 · Cited by 639
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.002 · Cited by 557
Diabetic cardiomyopathy: pathophysiology and clinical features
Miki, T., Yuda, S., Kouzu, H., & Miura, T. (2013) · Heart Failure Reviews · doi:10.1007/s10741-012-9313-3 · Cited by 460
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., de Oliveira, G. M. M., Simão, A. F. L., Dutra, Ó. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R., Giuliano, I. D. C. B., Filho, A. C. D. A., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 507
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure
Dei Cas, A., Khan, S. S., Butler, J., Mentz, R. J., Bonow, R. O., Avogaro, A., Tschoepe, D., Doehner, W., Greene, S. J., Senni, M., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.08.004 · Cited by 401
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
Hayat, S. A., Patel, B., Khattar, R. S., & Malik, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 353
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
Gilbert, R. E., & Krum, H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61402-1 · Cited by 303
pre-diabetes Task Force on diabetes (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 239
Cardiovascular Protection Using Beta-Blockers
Bangalore, S., Messerli, F. H., Kostis, J. B., & Pepine, C. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.060 · Cited by 233
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., & McMurray, J. J. V. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn156 · Cited by 227
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
III Diretriz Brasileira de Insuficiência Cardíaca Crônica
Bocchi, E. A., Marcondes‐Braga, F. G., Ayub‐Ferreira, S. M., Rohde, L. E. P., Junior, W. A. D. O., Almeida, D. R., Moreira, M. D. C. V., Bestetti, R. B., Bordignon, S., Azevedo, C., et al. (2009) · Americanae (AECID Library) · doi:10.1590/s0066-782x2009002000001 · Cited by 170
Krum, H., Jelinek, M. V., Stewart, S., Sindone, A. P., Atherton, J. J., & Hawkes, A. L. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00690.x · Cited by 167
Cubbon, R. M., Adams, B., Rajwani, A., Mercer, B. N., Patel, P. A., Gherardi, G., Gale, C. P., Batin, P. D., Ajjan, R., Kearney, L., et al. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112471064 · Cited by 167
Krum, H., & Abraham, W. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60236-1 · Cited by 166
MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J. R., & McAlister, F. A. (2010) · Diabetes Care · doi:10.2337/dc09-2227 · Cited by 149
Impact of Spirituality/Religiosity on Mortality: Comparison With Other Health Interventions
Lucchetti, G., Lucchetti, A. L. G., & Koenig, H. G. (2011) · EXPLORE · doi:10.1016/j.explore.2011.04.005 · Cited by 159
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.05.007 · Cited by 145
Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study
Bakris, G. L., Gaxiola, E., Messerli, F. H., Mancia, G., Erdine, S. E., Cooper‐DeHoff, R. M., & Pepine, C. J. (2004) · Hypertension · doi:10.1161/01.hyp.0000143851.23721.26 · Cited by 127
Metabolic dysfunction in diabetic cardiomyopathy
Isfort, M. C., Stevens, S. C. W., Schaffer, S. W., Jong, C. J., & Wold, L. E. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9377-8 · Cited by 128
Murarka, S., & Movahed, M. R. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.07.249 · Cited by 125
The Role of the New β-Blockers in Treating Cardiovascular Disease
Weber, M. A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.09.009 · Cited by 120
Wang, Q., Liu, Y., Fu, Q., Xu, B. Y., Zhang, Y., Kim, S., Tan, R., Barbagallo, F., West, T. M., Anderson, E. J., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022281 · Cited by 120
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
Wang, L., Cai, Y., Jian, L., Cheung, C. W., Zhang, L., & Xia, Z. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01188-0 · Cited by 116
The Real Role of β-Blockers in Daily Cardiovascular Therapy
Dézsi, C. A., & Szentes, V. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0221-8 · Cited by 117
Arnold, J. M. O., Howlett, J. G., Ducharme, A., Ezekowitz, J. A., Gardner, M. J., Giannetti, N., Haddad, H. A., Heckman, G. A., Isaac, D., Jong, P., et al. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70545-2 · Cited by 103
Packer, M. (2017) · Diabetes Care · doi:10.2337/dci17-0052 · Cited by 106
Heart Failure and Diabetes Mellitus: Epidemiology and Management of an Alarming Association
Solal, A. C., Beauvais, F., & Logeart, D. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.04.001 · Cited by 94
Diabetic cardiomyopathy: from pathophysiology to treatment.
Trachanas, K., Sideris, S. K., Aggeli, C., Poulidakis, E., Gatzoulis, K. A., Tousoulis, D. M., & Kallikazaros, I. E. (2014) · PubMed · Cited by 86
The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy
Wasserstrum, Y., Barriales-Villa, R., Fernández-Fernández, X., Adler, Y., Lotan, D., Peled, Y., Klempfner, R., Kuperstein, R., Shlomo, N., Sabbag, A., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy625 · Cited by 69
Approach and Management of Hypertension After Kidney Transplantation
Tantisattamo, E., Molnar, M. Z., Ho, B., Reddy, U. G., Dafoe, D. C., Ichii, H., Ferrey, A., Hanna, R. M., Kalantar‐Zadeh, K., & Amin, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00229 · Cited by 86
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 76
Authors Task Force Members, Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., et al. (2007) · European Heart Journal Supplements · doi:10.1093/eurheartj/ehl261 · Cited by 76
Diabetic cardiomyopathy – a distinct disease?
Khavandi, K., Khavandi, A., Asghar, O., Greenstein, A. S., Withers, S., Heagerty, A. M., & Malik, R. A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.016 · Cited by 72
Sharma, V. S., Dhillon, P., Wambolt, R. B., Parsons, H., Brownsey, R. W., Allard, M. F., & McNeill, J. H. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00949.2007 · Cited by 72
O’Keefe, J. H., Abuissa, H. S., & Pitt, B. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00730.x · Cited by 71
Systematic Review of Noncancer Presentations with a Median Survival of 6 Months or Less
Salpeter, S. R., Luo, E. J., Malter, D. S., & Stuart, B. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.028 · Cited by 70
Costs of Inpatient Care Among Medicare Beneficiaries With Heart Failure, 2001 to 2004
Whellan, D. J., Greiner, M. A., Schulman, K. A., & Curtis, L. H. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.854760 · Cited by 68
Bell, D. S. H., Ann Lukas, M., Holdbrook, F. K., & Fowler, M. B. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x80459 · Cited by 66
The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
Masarone, D., Martucci, M. L., Errigo, V., & Pacileo, G. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8090101 · Cited by 66
Pallangyo, P., Millinga, J., Bhalia, S. V., Mkojera, Z., Misidai, N., Swai, H. J., Hemed, N. R., Kaijage, A., & Janabi, M. (2020) · BMC Research Notes · doi:10.1186/s13104-020-04959-w · Cited by 66
Gilbert, R. E., Connelly, K. A., Kelly, D. J., Pollock, C. A., & Krum, H. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00540705 · Cited by 66
Morphological characteristics in diabetic cardiomyopathy associated with autophagy
Kanamori, H., Naruse, G., 吉田明弘, Minatoguchi, S., Watanabe, T., Kawaguchi, T., Tanaka, T., Yamada, Y., Takasugi, H., Mikami, A., et al. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.05.009 · Cited by 64
Carrasco-Sánchez, F. J., Gómez-Huelgas, R., Formiga, F., Martel, A. C., Trullàs, J. C., Bettencourt, P., Arévalo‐Lorido, J. C., & Montero-Pérez-Barquero, M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.015 · Cited by 64
The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
Ofstad, A. P., Atar, D., Gullestad, L. L., Langslet, G., & Johansen, O. E. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9685-0 · Cited by 59
Parissis, J. T., Rafouli-Stergiou, P., Mebazaa, A., Ikonomidis, I., Bistola, V., Nikolaou, M., Meas, T., Delgado, J., Vilas-Boas, F., Paraskevaidis, I., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.098 · Cited by 58
VersorgungsLeitlinie, N. (2011) · Cited by 58
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 109
Primordial Drivers of Diabetes Heart Disease: Comprehensive Insights into Insulin Resistance
Fan, Y., Yan, Z., Li, T., Li, A., Fan, X., Qi, Z., & Zhang, J. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0110 · Cited by 56
Metabolic Effects of ??-Adrenoceptor Antagonists with Special Emphasis on Carvedilol
Kveiborg, B., Christiansen, B., Major‐Pedersen, A., & Torp-Pedersen, C. T. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606040-00001 · Cited by 52
Fonarow, G. C., & Srikanthan, P. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.05.003 · Cited by 52
Sharma, A., Mah, M., Ritchie, R. H., & Blasio, M. J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108008 · Cited by 52
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 58
Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure
Newton, J. D., & Squire, I. B. (2006) · Heart · doi:10.1136/hrt.2005.080895 · Cited by 47
Thaung, H. P. A., Baldi, J. C., Wang, H.-Y., Hughes, G., Cook, R. F., Bussey, C. T., Sheard, P. W., Bahn, A., Jones, P. P., Schwenke, D. O., et al. (2015) · Diabetes · doi:10.2337/db14-0955 · Cited by 45
Wai, B., Kearney, L. G., Hare, D. L., Ord, M., Burrell, L. M., & Srivastava, P. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-14 · Cited by 43
Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
Seferović, J. P., Solomon, S. D., & Seely, E. W. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820970444 · Cited by 41
de Boer, R. A., Doehner, W., van der Horst, I. C. C., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J., Flather, M. D., & van Veldhuisen, D. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.02.018 · Cited by 39
Safety and tolerability of beta-blockers: prejudices and reality
Erdmann, E. (2009) · European Heart Journal Supplements · doi:10.1093/eurheartj/sup001 · Cited by 39
Nasir, S., & Aguilar, D. A. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.031 · Cited by 39
Karnik, A. A., Fields, A. V., & Shannon, R. P. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0086-3 · Cited by 37
Mentz, R. J., Bethel, M. A., Merrill, P., Lokhnygina, Y. V., Buse, J. B., Chan, J. C. N., Felício, J. S., Goodman, S. G., Choi, J., Gustavson, S. M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009304 · Cited by 36
Type 2 Diabetes Mellitus and Heart Failure
Choy, C. K., Rodgers, J. E., Nappi, J. M., & Haines, S. T. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.2.170 · Cited by 34
Chioncel, O., Davison, B. A., Adamo, M., Antohi, E., Arrigo, M., Barros, M., Biegus, J., Čerlinskaitė‐Bajorė, K., Čelutkienė, J., Solal, A. C., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.3039 · Cited by 34
Treatment of Diabetes in People With Heart Failure
Connelly, K. A., Gilbert, R. E., & Liu, P. X. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.026 · Cited by 35
Diabetes mellitus and the heart
Mercer, B. N., Morais, S. R. D. L. O. K., Cubbon, R. M., & Kearney, M. T. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02924.x · Cited by 33
Heart Failure in Diabetes and Related Conditions
Kamalesh, M. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.007 · Cited by 32
Aftab, W., Varadarajan, P., Rasool, S., Kore, A., & Pai, R. G. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.000091 · Cited by 32
Dorenkamp, M., Riad, A., Stiehl, S., Spillmann, F., Westermann, D., Du, J., Pauschinger, M., Noutsias, M., Adams, V., Schultheiss, H., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.020 · Cited by 32
Opasich, C., Boccanelli, A., Cafiero, M., Cirrincione, V., Sindaco, D. D., Lenarda, A. D., Luzio, S. D., Faggiano, P. M., Frigerio, M., Lucci, D., et al. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.11.005 · Cited by 31
(ESC), G. D. T. S. D. Y. E. C. D. L. S. E. D. C., & (EASD), D. L. S. E. P. E. E. D. L. D. (2007) · Revista Española de Cardiología · doi:10.1016/s0300-8932(07)75070-4 · Cited by 28
Contemporary Management of Heart Failure in Patients With Diabetes
Shaw, J. A., & Cooper, M. E. (2020) · Diabetes Care · doi:10.2337/dc20-2173 · Cited by 29
Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity
Etzion, S., Etzion, Y., DeBosch, B. J., Crawford, P. A., & Muslin, A. J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.011 · Cited by 27
Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
Beta-Blockers in Heart Failure Collaborative Group, Kotecha, D., Manzano, L., Altman, D. G., Krum, H., Erdem, G., Williams, N., & Flather, M. D. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-7 · Cited by 28
Sarafidis, P. A., & Bakris, G. L. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2005.04679.x · Cited by 28
Carvedilol and antioxidant proteins in a type I diabetes animal model
Diogo, C. V., Deus, C. M., Lebiedzińska, M., Wojtala, A., Wieckowski, M. R., & Oliveira, P. J. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12696 · Cited by 25
Go, Y. Y., Allen, J. C., Chia, S. Y., Sim, L. L., Jaufeerally, F. R., Yap, J. J. L., Ching, C. K., Sim, D., Kwok, B. W. K., & Liew, R. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.119 · Cited by 24
Sources of evidence for systematic reviews of interventions in diabetes
Royle, P., Bain, L., & Waugh, N. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01645.x · Cited by 24
The European Association for the Study of Diabetes
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1250 · Cited by 24
Shireman, T. I., Mahnken, J. D., Phadnis, M. A., & Ellerbeck, E. F. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0233-3 · Cited by 23
Bruijn, N., van Lohuizen, R., Boron, M., Fitzek, M. P., Gabriele, F., Giuliani, G., Melgarejo, L., Řehulka, P., Sebastianelli, G., Triller, P., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01724-3 · Cited by 23
Kim, J. Y., Kim, H. J., Jung, S., Kim, K., Song, H. J., Lee, J., Seong, J.-M., & Park, B. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-60 · Cited by 22
Documento de Consenso de Expertos sobre bloqueadores de los receptores ß-adrenérgicos
Beta, G. D. T. S. B., & de Cardiología, D. L. S. E. (2005) · Revista Española de Cardiología · doi:10.1157/13070510 · Cited by 22
Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., Ishii, H., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0865 · Cited by 24
Jacob, S., & Henriksen, E. J. (2004) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2004.03704.x · Cited by 20
Jorsal, A., Wiggers, H., & McMurray, J. J. V. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.007 · Cited by 20
Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus
Garcia-Egido, A. A., Andrey, J. L., Puerto, J. L., Aranda, R., Pedrosa, M. J., López‐Sáez, J. B., Rosety, M. Á., & Gomez, F. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12567 · Cited by 18
Larijani, B. A., Afshari, M., Astanehi-Asghari, F., Mojtahedi, A., Rezaie, A. R., Hossein‐Nezhad, A., Heshmat, R., Mohammadirad, A., & Abdollahi, M. R. (2006) · Therapy · doi:10.2217/14750708.3.1.119 · Cited by 18
Blonde, L., Dempster, J. S., Gallivan, J. M., & Warren‐Boulton, E. (2006) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2006.00171.x · Cited by 18
Rydén, L., estable, G. D. T. D. L. S. E. D. C. S. D. Y. T. D. L. C. I., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H. P., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.015 · Cited by 20
Woo, V. C., Connelly, K. A., Lin, P., & McFarlane, P. A. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1576479 · Cited by 17
the directors of the JCS, J., Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00471-5 · Cited by 16
Heart Failure in the Diabetic Patient
Bell, D. S. H. (2007) · Cardiology Clinics · doi:10.1016/j.ccl.2007.08.003 · Cited by 16
Diabetes and heart failure in the post-myocardial infarction patient
Estep, J. D., & Aguilar, D. A. (2006) · Current Heart Failure Reports · doi:10.1007/s11897-006-0017-7 · Cited by 16
Metadata
- Authors
- Haas, S. J., Vos, T., Gilbert, R. E., & Krum, H.
- Affiliations
- The Alfred Hospital (AU)
- The University of Melbourne (AU)
- Corresponding author
- Krum, Henry
- Venue
- American Heart Journal
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 146
- Issue
- 5
- Pages
- 848-853
- ISSN
- 0002-8703 (ISSN-L)
- OpenAlex
- W1975966089
- Cited by
- 194
- References
- 41
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 18 · 2019: 10 · 2018: 6 · 2017: 9 · 2016: 8 · 2015: 7 · 2014: 12 · 2013: 12 · 2012: 8
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- beta-blockers, chronic heart failure, diabetes mellitus, all-cause mortality, carvedilol, bisoprolol, metoprolol, beta-blocker contraindication, comorbidities
- MeSH terms
- Adrenergic beta-Antagonists, Diabetes Mellitus, Heart Failure, Humans, Comorbidity, Survival Rate, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
